| Lo JT, Chen BH, Lee TM, et al.
Self-emulsifying O/W formulations of paclitaxel prepared from mixed nonionic surfactants. [JOURNAL ARTICLE]
J Pharm Sci 2009 Nov 5.
Abstract | Full Citation | Find Related Articles | | Wirth LJ, Allen AM, Posner MR, et al.
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 5.
Abstract | Full Citation | Find Related Articles | | Lee CW, Park DW, Lee SH, et al.
Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction. [Journal Article, Research Support, Non-U.S. Gov't]
Am J Cardiol 2009 Nov 15; 104(10):1370-6.
Abstract | Full Citation | Find Related Articles | | Nienaber CA, Akin I, Schneider S, et al.
Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry). [Journal Article]
Am J Cardiol 2009 Nov 15; 104(10):1362-9.
Abstract | Full Citation | Find Related Articles | | Trost BM, Amans D, Seganish WM, et al.
Evaluating Transition-Metal-Catalyzed Transformations for the Synthesis of Laulimalide. [JOURNAL ARTICLE]
J Am Chem Soc 2009 Nov 5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | du Bois A, Huober J, Stopfer P, et al.
A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Reynolds C, Barrera D, Jotte R, et al.
Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell Lung Cancer. [JOURNAL ARTICLE]
J Thorac Oncol 2009 Oct 31.
Abstract | Full Citation | | Burns CJ, Fantino E, Phillips ID, et al.
CYT997: a novel orally active tubulin polymerization inhibitor with potent cytotoxic and vascular disrupting activity in vitro and in vivo. [JOURNAL ARTICLE]
Mol Cancer Ther 2009 Nov 3.
Abstract | Full Citation | | Bekaii-Saab TS, Roda JM, Guenterberg KD, et al.
A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies. [JOURNAL ARTICLE]
Mol Cancer Ther 2009 Nov 3.
Abstract | Full Citation | | Joly F, Sevin E, Lortholary A, et al.
Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: A Multicenter Phase II Trial. [JOURNAL ARTICLE]
Gynecol Oncol 2009 Nov 2.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
